Victory Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-144,080
| Closed | -$26.5M | – | 2894 |
|
|
2021
Q2 | $26.5M | Sell |
144,080
-10,756
| -7% | -$1.85M | 0.03% | 798 |
|
|
2021
Q1 | $23.7M | Sell |
154,836
-53,439
| -26% | -$8.27M | 0.02% | 849 |
|
|
2020
Q4 | $32.5M | Buy |
208,275
+17,833
| +9% | +$2.29M | 0.04% | 682 |
|
|
2020
Q3 | $21.8M | Buy |
190,442
+43,098
| +29% | +$4.65M | 0.03% | 757 |
|
|
2020
Q2 | $16.5M | Sell |
147,344
-102,250
| -41% | -$10.9M | 0.02% | 856 |
|
|
2020
Q1 | $22.4M | Buy |
249,594
+126,687
| +103% | +$12.4M | 0.02% | 848 |
|
|
2019
Q4 | $13.3M | Buy |
122,907
+6,272
| +5% | +$671K | 0.02% | 930 |
|
|
2019
Q3 | $11.4M | Sell |
116,635
-42,324
| -27% | -$4.77M | 0.01% | 943 |
|
|
2019
Q2 | $20.8M | Buy |
158,959
+15,892
| +11% | +$2.05M | 0.04% | 604 |
|
|
2019
Q1 | $19.3M | Buy |
143,067
+20,263
| +17% | +$2.52M | 0.04% | 579 |
|
|
2018
Q4 | $12M | Sell |
122,804
-26,657
| -18% | -$3.15M | 0.03% | 674 |
|
|
2018
Q3 | $20.8M | Sell |
149,461
-23,210
| -13% | -$2.91M | 0.04% | 596 |
|
|
2018
Q2 | $21.4M | Buy |
172,671
+27,973
| +19% | +$3.27M | 0.05% | 580 |
|
|
2018
Q1 | $16.1M | Buy |
144,698
+30,997
| +27% | +$3.7M | 0.04% | 639 |
|
|
2017
Q4 | $13.6M | Sell |
113,701
-7,441
| -6% | -$906K | 0.03% | 673 |
|
|
2017
Q3 | $17M | Buy |
121,142
+9,639
| +9% | +$1.31M | 0.04% | 625 |
|
|
2017
Q2 | $13.6M | Sell |
111,503
-12,374
| -10% | -$1.44M | 0.03% | 660 |
|
|
2017
Q1 | $15M | Sell |
123,877
-32,587
| -21% | -$4.2M | 0.04% | 639 |
|
|
2016
Q4 | $19.1M | Sell |
156,464
-12,877
| -8% | -$1.58M | 0.05% | 574 |
|
|
2016
Q3 | $20.8M | Sell |
169,341
-7,046
| -4% | -$907K | 0.06% | 546 |
|
|
2016
Q2 | $20.6M | Buy |
176,387
+18,108
| +11% | +$2.57M | 0.08% | 402 |
|
|
2016
Q1 | $22M | Buy |
158,279
+23,106
| +17% | +$3.39M | 0.09% | 384 |
|
|
2015
Q4 | $25.8M | Sell |
135,173
-94,966
| -41% | -$16.6M | 0.11% | 323 |
|
|
2015
Q3 | $36M | Sell |
230,139
-37,562
| -14% | -$6.85M | 0.15% | 222 |
|
|
2015
Q2 | $48.4M | Sell |
267,701
-44,606
| -14% | -$7.7M | 0.18% | 174 |
|
|
2015
Q1 | $54.1M | Sell |
312,307
-20,153
| -6% | -$3.65M | 0.19% | 173 |
|
|
2014
Q4 | $61.5M | Buy |
332,460
+136,280
| +69% | +$25.3M | 0.23% | 137 |
|
|
2014
Q3 | $32.5M | Sell |
196,180
-88,926
| -31% | -$14.6M | 0.25% | 147 |
|
|
2014
Q2 | $44.5M | Sell |
285,106
-14,239
| -5% | -$2.25M | 0.3% | 109 |
|
|
2014
Q1 | $45.5M | Buy |
299,345
+16,705
| +6% | +$2.66M | 0.31% | 113 |
|
|
2013
Q4 | $37.6M | Sell |
282,640
-113,242
| -29% | -$13.6M | 0.27% | 136 |
|
|
2013
Q3 | $46M | Buy |
+395,882
| New | +$43.4M | 0.33% | 95 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM